Propylthiouracil before 131I therapy of hyperthyroid diseases:: Effect on cure rate evaluated by a randomized clinical trial

被引:56
作者
Bonnema, SJ [1 ]
Bennedbæk, FN
Veje, A
Marving, J
Hegedüs, L
机构
[1] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Dept Nucl Med, DK-5000 Odense C, Denmark
关键词
D O I
10.1210/jc.2004-0247
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A randomized clinical trial was performed to clarify whether pretreatment with propylthiouracil (PTU) before radioiodine ((131)I) therapy influences the final outcome of this therapy, as has been indicated by retrospective studies. Untreated consecutive hyperthyroid patients with Graves' disease (n=23) or a toxic nodular goiter (n=57) were randomized to either PTU (+PTU; n=39) or no pretreatment (-PTU; n=41) before compensated (131)I therapy. The median PTU dose was 100 mg, which was discontinued 4 d before treatment. The median (131)I activity was 302 MBq (range, 87-600 MBq). After (131)I therapy, the serum free T(4) index increased in the +PTU group from 97.7+/-47.5(+/-SD) nmol/liter at the time of therapy to 152.3+/-77.6 nmol/liter at 3 wk (P<0.001) and 140.4 +/- 75.9 nmol/liter at 6 wk (P<0.001). In the -PTU group, the serum free T(4) index, which was initially 254.3+/-145.7 nmol/liter, decreased significantly to 212.0+/-113.0 nmol/liter at 3wk (P<0.05) and 165.8 +/- 110.0 nmol/liter at 6 wk (P<0.005). After 1 yr of follow-up, the treatment failure rate in patients with a toxic nodular goiter was four times higher in the +PTU group than in the -PTU group (nine of 20 vs. three of 25 patients; P=0.06), whereas the difference among patients with Graves' disease was less obvious (four of six vs. four of nine; P=0.81). Patients in the +PTU group who were cured had higher serum TSH (s-TSH) levels at the time of (131)I therapy than those who were not cured. By adjusting for a possible interfactorial relationship through a regression analysis, including the s-TSH level and type of disease, only PTU pretreatment had a significant adverse effect on the cure rate (P=0.03). In conclusion, this randomized trial demonstrates that PTU pretreatment reduces the cure rate of (131)I therapy in hyperthyroid diseases, although this adverse effect seems to be attenuated by the concomitant rise in s-TSH.
引用
收藏
页码:4439 / 4444
页数:6
相关论文
共 33 条
[1]   Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis [J].
Ahmad, AM ;
Ahmad, M ;
Young, ET .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (06) :767-775
[2]   High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease [J].
Alexander, EK ;
Larsen, PR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1073-1077
[3]   Radioiodine treatment of hyperthyroidism - Prognostic factors for outcome [J].
Allahabadia, A ;
Daykin, J ;
Sheppard, MC ;
Gough, SCL ;
Franklyn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3611-3617
[4]   Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism [J].
Andrade, VA ;
Gross, JL ;
Maia, AL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4012-4016
[5]   The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: One-year follow-up of a prospective, randomized study [J].
Andrade, VA ;
Gross, JL ;
Maia, AL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3488-3493
[6]   COMPARISON OF PROPRANOLOL AND CARBIMAZOLE AS ADJUNCTS TO I-131 THERAPY OF HYPERTHYRODISM [J].
ARO, A ;
HUTTUNEN, JK ;
LAMBERG, BA ;
PELKONEN, R ;
IKKALA, E ;
KUUSISTO, A ;
RISSANEN, V ;
SALMI, J ;
TERVONEN, S .
ACTA ENDOCRINOLOGICA, 1981, 96 (03) :321-327
[7]   Resumption of methimazole after 131I therapy of hyperthyroid diseases:: effect on thyroid function and volume evaluated by a randomized clinical trial [J].
Bonnema, SJ ;
Bennedbæk, FN ;
Gram, J ;
Veje, A ;
Marving, J ;
Hegedüs, L .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (06) :485-492
[8]   Controversies in radioiodine therapy:: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres [J].
Bonnema, SJ ;
Bartalena, L ;
Toft, AD ;
Hegedüs, L .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (01) :1-11
[9]   The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: A randomized clinical trial [J].
Braga, M ;
Walpert, N ;
Burch, HB ;
Solomon, BL ;
Cooper, DS .
THYROID, 2002, 12 (02) :135-139
[10]   The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after 131I ablation for Graves disease [J].
Burch, HB ;
Solomon, BL ;
Cooper, DS ;
Ferguson, P ;
Walpert, N ;
Howard, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3016-3021